Moderna

Key Takeaways:Moderna's updated COVID-19 mRNA vaccine, targeting the JN.1 variant EMA’s positive opinion marks a significant milestone in ensuring public health protection Moderna’s...

Key TakeawaysThe Taiwan FDA has approved Moderna’s updated Spikevax COVID-19 vaccine, targeting the JN.1 variant, for individuals six months and older, expanding protection...

Key TakeawaysModerna’s updated Spikevax® JN.1 COVID-19 vaccine has received MHRA approval in the UK, targeting the JN.1 Omicron subvariant to protect high-risk individuals...

Key Takeaways:Japan’s Ministry of Health has approved Moderna’s updated COVID-19 vaccine, targeting the JN.1 variant. The vaccine aligns with WHO recommendations and is...

Key Takeaways:Moderna’s mRESVIA vaccine has received European Commission approval for protecting adults aged 60+ against RSV. The approval is based on robust clinical...

Moderna, Inc. and Mitsubishi Tanabe Pharma Corporation announced a joint agreement for the co-promotion of Moderna's mRNA respiratory vaccine portfolio in Japan, including its...

Moderna's novel mRNA respiratory syncytial virus (RSV) vaccine, mRESVIA, has received a positive opinion from the European Medicines Agency's (EMA) Committee for Medicinal Products...

For the second time in six months, the European Medicines Agency's (EMA) European Committee for Medicinal Products for Human Use (CHMP) has rejected Apellis’...

Respiratory syncytial virus (RSV) vaccine mResvia (formerly mRNA-1345) has secured FDA approval, marking a significant milestone for Moderna as it seeks to diversify its...

Moderna, renowned for its groundbreaking contributions to combatting the COVID-19 pandemic with its innovative vaccines, embarked on a new frontier by venturing into the...

Moderna has been a pioneer at the intersection of science, technology, and health, embracing machine learning and artificial intelligence (AI) since its inception to...

Eli Lilly, Novo Nordisk, Moderna, and Regeneron achieved robust quarterly earnings, attributing it to the success of their drug and pipeline development initiatives. Eli...

An agreement has been reached where Moderna will use Caris Life Sciences' library of de-identified, multi-modal health data solutions. These solutions have been generated...